Cellares — HyperSinc

General InformationCellares is a deep-tech company based in California, founded in 2019, with 51-200 employees, developing automated cell therapy manufacturing platforms using robotics and bioreactor technology.

Funding & FinancialsCellares has raised approximately $80-100 million across multiple rounds, with Series B funding led by top-tier biotech and venture investors including Khosla Ventures and others.

Leadership & TeamCellares was founded by Obermeyer and team members with backgrounds in bioengineering and automated manufacturing; leadership includes experienced executives from biopharmaceutical and robotics sectors.

Recent ActivityCellares has been expanding partnerships with major biopharmaceutical companies for manufacturing automation of cell therapies and scaling its closed-system bioreactor platform for commercial production.

Highlights

Total Raised

—

1 rounds

Latest Round

$20

Jun 13, 2026

Stage

Series B

deep-tech

Employees

51-200

Founded 2019

Headquarters

News Coverage

—

Talent Signals

—

SEC Filings

—

Backers

ARK Invest

Baillie Gifford

BlackRock

DC Global Ventures

DFJ Growth

Duquesne Family Office

Eclipse

EDBI

Gates Frontier

Intuitive Ventures

T. Rowe Price Investment Management

Willett Advisors

Funding History

$20

2026

Series D

SEC Form D Editorial

Jun 13, 2026

$20 millionSeries D · Editorial

Investors: ARK Invest, BlackRock, Eclipse, T. Rowe Price Investment Management, Baillie Gifford, Duquesne Family Office, Intuitive Ventures, EDBI, Gates Frontier, DC Global Ventures, DFJ Growth, Willett Advisors

Cellares, an integrated development and manufacturing organization for automated cell therapy production, received a $20 million investment from ARK Invest, bringing its Series D to $277 million total for scaling global smart factories.

Similar Companies 6

Enigma Aina Humanoid MICROPURE GENOMICS INC.AVANT GENOMICS, LLC PHOTONECT INTERCONNECT SOLUTIONS INC